loadpatents
name:-0.010518074035645
name:-0.010432004928589
name:-0.00038719177246094
Matassa; Victor Giulio Patent Filings

Matassa; Victor Giulio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Matassa; Victor Giulio.The latest application filed is for "pyrrolotriazinone derivatives as pi3k inhibitors".

Company Profile
0.10.17
  • Matassa; Victor Giulio - Barcelona N/A ES
  • Matassa; Victor Giulio - Sant Feliu de Llobregat ES
  • Matassa; Victor Giulio - La Floresta ES
  • Matassa; Victor Giulio - Hirschberg DE
  • Matassa; Victor Giulio - Rome IT
  • Matassa; Victor Giulio - Furneux Pelham GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrrolotriazinone derivatives as inhibitors P13K
Grant 9,340,547 - Bernal Anchuela , et al. May 17, 2
2016-05-17
Pyrrolotriazinone Derivatives As Pi3k Inhibitors
App 20150099752 - Bernal Anchuela; Francisco Javier ;   et al.
2015-04-09
Pyrrolotriazinone Derivatives As P13k Inhibitors
App 20140163033 - Bernal Anchuela; Francisco Javier ;   et al.
2014-06-12
Imidazopyridine Derivatives As Jak Inhibitors
App 20130216498 - Eastwood; Paul Robert ;   et al.
2013-08-22
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptors
Grant 8,178,679 - Matassa , et al. May 15, 2
2012-05-15
Substituted Indolin-2-one Derivatives And Their Use As P38 Mitogen-activated Kinase Inhibitors
App 20110046097 - Eastwood; Paul Robert ;   et al.
2011-02-24
Dpp-Iv Inhibitors
App 20080275086 - Edwards; Paul John ;   et al.
2008-11-06
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
Grant 7,417,064 - Boulet , et al. August 26, 2
2008-08-26
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
Grant 7,410,996 - Boulet , et al. August 12, 2
2008-08-12
Dpp-IV Inhibitors
App 20080176838 - Edwards; Paul John ;   et al.
2008-07-24
Dpp-IV Inhibitors
App 20080015146 - Edwards; Paul John ;   et al.
2008-01-17
[1,2,4]Triazolo[4,3-A]Pyridine Derivatives for the Treatment of Hyperproliferative Diseases
App 20070299103 - Abel; Ulrich ;   et al.
2007-12-27
Dpp-IV Inhibitors
App 20070265261 - Edwards; Paul John ;   et al.
2007-11-15
Dpp-IV Inhibitors
App 20070265301 - Edwards; Paul John ;   et al.
2007-11-15
Dpp-iv inhibitors
App 20070197522 - Edwards; Paul John ;   et al.
2007-08-23
Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors
App 20070099927 - Feurer; Achim ;   et al.
2007-05-03
Peptides and their use as inhibitors of hepatitis C virus ns3 protease
Grant 7,119,073 - Colarusso , et al. October 10, 2
2006-10-10
3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake
App 20060014779 - Boulet; Serge Louis ;   et al.
2006-01-19
Peptides and their use as inhibitors of hepatitis c virus ns3 protease
App 20040142876 - Colarusso, Stefania ;   et al.
2004-07-22
Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists
Grant 6,025,374 - Castro Pineiro , et al. February 15, 2
2000-02-15
Azetidine, pyrrolidine and piperidine derivatives
Grant 5,854,268 - Baker , et al. December 29, 1
1998-12-29
Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT.sub.1D receptor agonists
Grant 5,849,746 - Chambers , et al. December 15, 1
1998-12-15
Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
Grant 5,696,110 - Bourrain , et al. December 9, 1
1997-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed